Literature DB >> 20155478

Some physicochemical properties of the antitumor drug thiotepa and its metabolite tepa as obtained by density functional theory (DFT) calculations.

Djaffar Kheffache1, Ourida Ouamerali.   

Abstract

Density functional theory (DFT) using the B3LYP functional was applied to elucidate the molecular properties of the antitumor drug thiotepa and its main metabolite tepa. Aqueous solvent effects were introduced using the conductor-like polarizable continuum model (CPCM). The protocol for calculating the pK (a) values obtained with different cavity models was tested on a series of aziridine and phosphoramide compounds. An efficient computational scheme has been identified that uses the CPCM model of solvation with a universal force field (UFF) cavity. The method has been used to evaluate the basicities of thiotepa and its metabolite. Our calculations show that the basicities of the aziridine moiety of thiotepa and tepa are dramatically reduced compared to free aziridine, indicating that highly acidic media are needed to produce substantial yields of the N-protonated form of the drug. Finally, the mechanisms of reaction of the drug and its metabolite are discussed based on our theoretical results. The calculations reproduce the experimental trends very satisfactorily.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155478     DOI: 10.1007/s00894-010-0658-z

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  17 in total

1.  A search for new metabolites of N,N',N''-triethylenethiophosphoramide.

Authors:  M J van Maanen; I M Tijhof; J M Damen; C Versluis; J J van den Bosch; A J Heck; S Rodenhuis; J H Beijnen
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

2.  Stability of thioTEPA and its metabolites, TEPA, monochloroTEPA and thioTEPA-mercapturate, in plasma and urine.

Authors:  M J van Maanen; K Doesburg Smits; J M Damen; A J Heck; J H Beijnen
Journal:  Int J Pharm       Date:  2000-05-10       Impact factor: 5.875

3.  The degradation of N,N',N"-triethylenephosphoramide in aqueous solutions: a qualitative and kinetic study.

Authors:  R J van Maanen; I M Tijhof; J M Damen; J W Zwikker; J H Beijnen
Journal:  Int J Pharm       Date:  2000-02-25       Impact factor: 5.875

Review 4.  Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA).

Authors:  M J Maanen; C J Smeets; J H Beijnen
Journal:  Cancer Treat Rev       Date:  2000-08       Impact factor: 12.111

5.  Alkylation of DNA with aziridine produced during the hydrolysis of N,N',N''-triethylenethiophosphoramide.

Authors:  S M Musser; S S Pan; M J Egorin; D J Kyle; P S Callery
Journal:  Chem Res Toxicol       Date:  1992 Jan-Feb       Impact factor: 3.739

6.  Degradation study of thiotepa in aqueous solutions.

Authors:  M J van Maanen; A C Brandt; J M Damen; J H Beijnen
Journal:  Int J Pharm       Date:  1999-03-01       Impact factor: 5.875

7.  Dependence of the biological activity and mass spectrometric pattern on the structure peculiarities of the molecule of alkylating drug thiotepa.

Authors:  M V Kosevich; V S Shelkovsky; S G Stepanian
Journal:  Biophys Chem       Date:  1996-01       Impact factor: 2.352

8.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

Review 9.  High-dose chemotherapy regimens for solid tumors.

Authors:  E van der Wall; J H Beijnen; S Rodenhuis
Journal:  Cancer Treat Rev       Date:  1995-03       Impact factor: 12.111

10.  Protonation of phosphoramide mustard and other phosphoramides.

Authors:  M P Gamcsik; S M Ludeman; E M Shulman-Roskes; I J McLennan; M E Colvin; O M Colvin
Journal:  J Med Chem       Date:  1993-11-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.